SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-23-000194
Filing Date
2023-02-14
Accepted
2023-02-14 17:24:04
Documents
2
Group Members
ORBIMED CAPITAL GP IV LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss1758642_sc13ga.htm SC 13G/A 65254
2 JOINT FILING AGREEMENT ss1758642_ex99a.htm EX-99.A 5581
  Complete submission text file 0000947871-23-000194.txt   72483
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 23631855
SIC: 2836 Biological Products, (No Diagnostic Substances)